Tyrosine kinase inhibitors (TKI): agents

Evidence-based neurology checklist on tyrosine kinase inhibitors (tki): agents: ALK inhibitors Alectinib Brigatinib Ensartinib BTK inhibitors EGFR inhibitors FGFR inhibitors HER2 inhibitors JAK 1 and 2 inhibitors KIT inhibitors MEK inhibitors MET inhibitors RET inhibitors SRC inhibitors TRK…

ALK inhibitors

  • Alectinib
  • Brigatinib
  • Ensartinib

BTK inhibitors

EGFR inhibitors

FGFR inhibitors

HER2 inhibitors

JAK 1 and 2 inhibitors

KIT inhibitors

MEK inhibitors

MET inhibitors

RET inhibitors

SRC inhibitors

TRK inhibitors

VEGFR inhibitors

Multi-target inhibitors

References

  1. Jiao Q, Bi L, Ren Y, Song S, Wang Q, Wang YS. Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Mol Cancer 2018; 17:36.
  2. Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020). J Hematol Oncol 2020; 13:143.

Related checklists

Loading...